ORACEA (doxycycline) is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. No meaningful effect was demonstrated for generalized erythema (redness) of rosacea.
Limitations of Use
This formulation of doxycycline has not been evaluated in the treatment or prevention of infections. ORACEA (doxycycline) should not be used for treating bacterial infections, providing antibacterial prophylaxis, or reducing the numbers or eliminating microorganisms associated with any bacterial disease. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, ORACEA (doxycycline) should be used only as indicated.
Efficacy of ORACEA (doxycycline) beyond 16 weeks and safety beyond 9 months have not been established.
ORACEA (doxycycline) has not been evaluated for the treatment of the erythematous, telangiectatic, or ocular components of rosacea.
DOSAGE AND ADMINISTRATION
General Dosing Information
One ORACEA (doxycycline) Capsule (40 mg) should be taken once daily in the morning on an empty stomach, preferably at least one hour prior to or two hours after meals. Administration of adequate amounts of fluid along with the capsules is recommended to wash down the capsule to reduce the risk of esophageal irritation and ulceration [see ADVERSE REACTIONS].
Important Considerations for Dosing Regimen
The dosage of ORACEA differs from that of doxycycline used to treat infections. Exceeding the recommended dosage may result in an increased incidence of side effects including the development of resistant organisms.
Dosage Forms And Strengths
40 mg capsule: beige opaque capsule imprinted with “GLD 40”
Storage And Handling
ORACEA (doxycycline) (beige opaque capsule imprinted with “GLD 40”) containing doxycycline, USP in an amount equivalent to 40 mg of anhydrous doxycycline. Bottle of 30 (NDC 0299-3822-30).
All products are to be stored at controlled room temperatures of 15°C - 30°C (59°F - 86°F) and dispensed in tight, light-resistant containers (USP).
KEEP OUT OF REACH OF CHILDREN
Marketed by: GALDERMA LABORATORIES, L.P. Fort Worth, Texas 76177 USA. Manufactured by: Catalent Pharma Solutions, LLC Winchester, Kentucky 40391 USA.
Last reviewed on RxList: 6/11/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Oracea Information
Oracea - User Reviews
Oracea User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.